Enterprise Financial Services Corp Galapagos Nv Transaction History

Enterprise Financial Services Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$52.17 - $70.2 $1,460 - $1,965	-28 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$68.86 - $83.34 $68 - $83	1 Added 3.7%	28 $2,000
Q1 2021 May 13, 2021	BUY	$76.15 - $111.94 $1,675 - $2,462	22 Added 440.0%	27 $2,000
Q4 2020 Feb 12, 2021	SELL	$96.85 - $148.25 $1,452 - $2,223	-15 Reduced 75.0%	5 $0
Q3 2020 Nov 13, 2020	BUY	$122.47 - $213.56 $122 - $213	1 Added 5.26%	20 $3,000
Q2 2020 Aug 04, 2020	BUY	$185.52 - $231.25 $1,855 - $2,312	10 Added 111.11%	19 $4,000
Q1 2020 May 15, 2020	BUY	$143.0 - $274.03 $1,287 - $2,466	9 New	9 $2,000

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.76B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Enterprise Financial Services Corp, based on Form 13F filings with the SEC.

Stay updated on Enterprise Financial Services Corp with notifications on news.